Łukasz Jan Kolonko
age 50Currently 5 roles in 3 KRS entities. In the KRS since 2016.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
3 Heads sp. z o.o. |
since Apr 3, 2019 | Apr 3, 2019 | al. Tadeusza Rejtana 23/1.2 A, 35-326 Rzeszów |
since Aug 21, 2023 | Aug 21, 2023 | ul. Samuela Bogumiła Lindego 1C, 30-148 Kraków | |
P6 Pharma sp. z o.o. |
since Feb 21, 2025 | Feb 21, 2025 | ul. Samuela Bogumiła Lindego 1C, 30-148 Kraków |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Removed from the register | Vice President of the Management Board, Partner (33.33% of shares worth PLN 10,000) Bellis Pharma sp. z o.o. | Bellis Pharma sp. z o.o. | |
| Bankruptcy proceedings closed | – Bellis Pharma sp. z o.o. | Bellis Pharma sp. z o.o. | |
| Company founded | Partner (15% of shares worth PLN 750) P6 Pharma sp. z o.o. | P6 Pharma sp. z o.o. | |
| Company founded | Vice President of the Management Board, Partner (50% of shares worth PLN 5,000) | ||
| Bankruptcy proceedings closed | – Bellis Pharma sp. z o.o. | Bellis Pharma sp. z o.o. | |
| Bankruptcy declared | Bankruptcy (sygn. VIII GU 99/21/S) Bellis Pharma sp. z o.o. | Bellis Pharma sp. z o.o. | |
| Business resumed | – 3 Heads sp. z o.o. | 3 Heads sp. z o.o. | |
| Business suspended | – 3 Heads sp. z o.o. | 3 Heads sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation |
|
Sanctions list | None |
Inactive entity |
|
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Damian Marcin Pilichage 43 | since Apr 3, 2019 | ||
Szczepan Mikołaj Chmuraage 55 | since Apr 3, 2019 | ||
Krzysztof Kowaleczkoage 51 | P6 Pharma sp. z o.o. | since Feb 21, 2025 | |
Marek Nowakage 48 | Bellis Pharma sp. z o.o. | period unknown | |
Bellis Pharma sp. z o.o. | Sep 28, 2016 – Oct 8, 2026 |